These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 20213024)

  • 1. Periodontal disease and the oral-systemic connection: "is it all the RAGE?".
    Katz J; Wallet S; Cha S
    Quintessence Int; 2010 Mar; 41(3):229-37. PubMed ID: 20213024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.
    Stern DM; Yan SD; Yan SF; Schmidt AM
    Ageing Res Rev; 2002 Feb; 1(1):1-15. PubMed ID: 12039445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAGE: a multi-ligand receptor unveiling novel insights in health and disease.
    Alexiou P; Chatzopoulou M; Pegklidou K; Demopoulos VJ
    Curr Med Chem; 2010; 17(21):2232-52. PubMed ID: 20459381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.
    Yan SF; Ramasamy R; Schmidt AM
    J Mol Med (Berl); 2009 Mar; 87(3):235-47. PubMed ID: 19189073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications.
    Ramasamy R; Yan SF; Schmidt AM
    Ann N Y Acad Sci; 2011 Dec; 1243():88-102. PubMed ID: 22211895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periodontal disease and type 2 diabetes mellitus: is the HMGB1-RAGE axis the missing link?
    Morimoto-Yamashita Y; Ito T; Kawahara K; Kikuchi K; Tatsuyama-Nagayama S; Kawakami-Morizono Y; Fijisawa M; Miyashita K; Emoto M; Torii M; Tokuda M
    Med Hypotheses; 2012 Oct; 79(4):452-5. PubMed ID: 22800803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo.
    Riuzzi F; Sorci G; Donato R
    J Biol Chem; 2006 Mar; 281(12):8242-53. PubMed ID: 16407300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAGE: a journey from the complications of diabetes to disorders of the nervous system - striking a fine balance between injury and repair.
    Rong LL; Gooch C; Szabolcs M; Herold KC; Lalla E; Hays AP; Yan SF; Yan SS; Schmidt AM
    Restor Neurol Neurosci; 2005; 23(5-6):355-65. PubMed ID: 16477098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature.
    Yan SF; Ramasamy R; Schmidt AM
    Circ Res; 2010 Mar; 106(5):842-53. PubMed ID: 20299674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.
    Schmidt AM; Yan SD; Wautier JL; Stern D
    Circ Res; 1999 Mar; 84(5):489-97. PubMed ID: 10082470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced interaction of advanced glycation end products with their cellular receptor RAGE: implications for the pathogenesis of accelerated periodontal disease in diabetes.
    Lalla E; Lamster IB; Schmidt AM
    Ann Periodontol; 1998 Jul; 3(1):13-9. PubMed ID: 9722686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system.
    Hori O; Brett J; Slattery T; Cao R; Zhang J; Chen JX; Nagashima M; Lundh ER; Vijay S; Nitecki D
    J Biol Chem; 1995 Oct; 270(43):25752-61. PubMed ID: 7592757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor for advanced glycation end products, inflammation, and accelerated periodontal disease in diabetes: mechanisms and insights into therapeutic modalities.
    Lalla E; Lamster IB; Stern DM; Schmidt AM
    Ann Periodontol; 2001 Dec; 6(1):113-8. PubMed ID: 11887453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of the receptor for advanced glycation end products (RAGE) in inflammation].
    Mosquera JA
    Invest Clin; 2010 Jun; 51(2):257-68. PubMed ID: 20928981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biology of the receptor for advanced glycation end products and its ligands.
    Schmidt AM; Yan SD; Yan SF; Stern DM
    Biochim Biophys Acta; 2000 Dec; 1498(2-3):99-111. PubMed ID: 11108954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond.
    Ramasamy R; Yan SF; Schmidt AM
    Trends Cardiovasc Med; 2005 Oct; 15(7):237-43. PubMed ID: 16226677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAGE and its ligands in retinal disease.
    Barile GR; Schmidt AM
    Curr Mol Med; 2007 Dec; 7(8):758-65. PubMed ID: 18331234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGB1 and RAGE in inflammation and cancer.
    Sims GP; Rowe DC; Rietdijk ST; Herbst R; Coyle AJ
    Annu Rev Immunol; 2010; 28():367-88. PubMed ID: 20192808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N -Glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth.
    Srikrishna G; Huttunen HJ; Johansson L; Weigle B; Yamaguchi Y; Rauvala H; Freeze HH
    J Neurochem; 2002 Mar; 80(6):998-1008. PubMed ID: 11953450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review.
    Nguyen AH; Detty SQ; Agrawal DK
    Anticancer Res; 2017 Jan; 37(1):1-7. PubMed ID: 28011467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.